XTL Biopharmaceuticals Ltd (H2K2) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd (H2K2) has a Cash Flow Quality Index of -2.41x as of December 2021. Operating cash flow of €-1.05 Million is below net income of €435.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore XTL Biopharmaceuticals Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check XTL Biopharmaceuticals Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd (2018–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd. For live market cap and the full company financial profile, see XTL Biopharmaceuticals Ltd market cap and net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | €-1.05 Million | €435.00K | ▼ -972.8% |
| 2018 | -0.22x | €-816.00K | €3.63 Million | — |